Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02173808 · ClinicalTrials.gov registry record · Phase 1
A Phase I Study to Evaluate the PK and PD of a Single Injection of Levonorgestrel Butanoate for Female Contraception
A Phase 1 study of Contraceptive Usage, sponsored by Premier Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT02173808 is a Phase 1 study of Contraceptive Usage that has completed, run by Premier Research. The registered enrollment target is 16 participants, below the 627-participant average among 11 other Contraceptive Usage trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02173808, a Phase 1 study of Contraceptive Usage, has completed, sponsored by Premier Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the levonorgestrel (LNG) pharmacokinetic (PK) profile following injection of a single 20 mg dose of levonorgestrel butanoate (LB).
Conditions Studied
Interventions
- BIOLOGICAL levonorgestrel butanoate
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02173808
The ClinicalTrials.gov registry entry for NCT02173808 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 627-participant average among 11 other Contraceptive Usage trials with a reported enrollment target (97% lower). The listed sponsor is Premier Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Contraceptive Usage appearing as the primary indexed condition, and to 1 intervention - of which levonorgestrel butanoate is the first listed.
NCT02173808 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT02173808 about?
NCT02173808 is a clinical study titled "A Phase I Study to Evaluate the PK and PD of a Single Injection of Levonorgestrel Butanoate for Female Contraception". To evaluate the levonorgestrel (LNG) pharmacokinetic (PK) profile following injection of a single 20 mg dose of levonorgestrel butanoate (LB).
What is the current status of trial NCT02173808?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2011-05. Estimated completion is 2012-06.
What conditions does trial NCT02173808 study?
This clinical trial studies the following conditions: Contraceptive Usage.
What interventions are being tested in trial NCT02173808?
The interventions under investigation include: levonorgestrel butanoate (BIOLOGICAL).
Who is sponsoring clinical trial NCT02173808?
This trial is sponsored by Premier Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02173808 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraceptive Usage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlanta, GA
RECRUITING · Early Phase 1
-
Disparities in Emergency Contraceptive Metabolism Dictate Efficacy
RECRUITING · Phase 4
-
Effectiveness Testing of a Videogame Intervention (No Baby No) to Decrease Contraception Non-use Among Adolescents.
RECRUITING · NA
-
RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users
ACTIVE NOT RECRUITING · Phase 4
-
The Over The Counter Pill National Study
ACTIVE NOT RECRUITING
-
Sexual Health Empowerment for Women's Health
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.